TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
GNTA

Genenta Science SpA

Healthcare · Biotechnology

0.6903$ +0.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GNTA
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
96.5% 94.5% 96.8% 94.9% 95.1% 97.6% 94.0%
94.3% 88.4% 93.0% 89.1% 16.5% 30.9% 17.3%
94.3% 88.4% 93.0% 89.1% 84.0% 85.4% 88.3%
2.0% 4.3% 3.5% 4.7% 9.0% 9.8% 4.0%
-0.8% 0.2% 0.2% 0.4% 0.0% – –
– 0.1% – – – – –
– – – – -0.2% – –
– – – 0.0% 0.2% 0.6% –
11.7% 13.4% 2.9% 6.9% 8.6% 15.7% 31.5%
11.6% 13.3% 2.8% 6.5% 7.8% 14.2% 6.6%
– – – – – 0.1% –
2.7% 3.2% 0.5% 3.6% 1.3% 2.1% 4.7%
– – – – – – 23.8%
88.3% 86.6% 97.1% 93.1% 91.4% 84.3% 68.5%
-74.5% -122.8% -67.5% -106.1% -211.0% -378.1% -196.3%
84.9% 103.5% 45.5% 54.5% 81.5% 123.3% 61.8%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?